Care

The insurer said the new offering will be included in the majority of its commercial health plans.

nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.

Amplo led the capital raise for the surrogacy connection platform.

The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.

A review of studies published in npj Digital Medicine found digital and face-to-face CBT show similar effectiveness for treating depression.  

Smart stethoscope company Eko received a $2.7 million grant from the National Institutes of Health, and Halo raised $2.6 million for its research and development collaboration tool.

The company announced a $200 million Series C round in January.

The startup will use the seed funding to launch services in California, Texas and Washington this year.

The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.

The Cigna subsidiary said the tools included in its formulary were reviewed by physicians, pharmacists and user experience experts.